Dr. Komal Jhaveri

Dr. Komal Jhaveri, MD, is a distinguished breast medical oncologist and clinical researcher renowned for her expertise in treating complex breast cancers and advancing targeted therapies. She serves as an Associate Attending Physician in the Breast Medicine Service and Early Drug Development Service at Memorial Sloan Kettering Cancer Center, and holds an academic appointment as Associate Professor of Medicine at Weill Cornell Medical College. Dr. Jhaveri received her medical degree from the Maharaja Sayajirao University of Baroda and completed her internal medicine residency and hematology/oncology fellowship at Montefiore Medical Center and Albert Einstein College of Medicine. She is board-certified in medical oncology, hematology, and internal medicine.

Dr. Jhaveri is highly regarded for her leadership in clinical trials exploring novel therapeutic approaches, particularly for HER2-positive and triple-negative breast cancers. Her work focuses on integrating molecular insights into clinical practice, helping to shape the development of next-generation targeted treatments and antibody-drug conjugates. As a principal investigator on multiple early-phase studies, she has played a critical role in bringing innovative agents from the lab to the clinic. Her research has been extensively published in leading peer-reviewed journals and presented at major oncology conferences, contributing to evolving standards in breast cancer care.

A passionate educator and mentor, Dr. Jhaveri is deeply committed to fostering the next generation of oncologists and clinical scientists. She is actively involved in several national and international oncology organizations, including the American Society of Clinical Oncology (ASCO), where she contributes to guideline development and research advocacy. With a career marked by scientific rigor, compassionate care, and collaborative leadership, Dr. Jhaveri continues to shape the future of precision oncology and breast cancer therapeutics.